U.S. BIRTHCONTROL R&D LAGS

PEDIATRICS ◽  
1991 ◽  
Vol 88 (3) ◽  
pp. A102-A102

The U.S. has fallen behind other countries in developing contraceptives, depriving Americans of birth control choices available elsewhere, a study by the Institute of Medicine reports. All but one of the major pharmaceutical companies in the U.S. have stopped significant contraceptive research, and new birth control techniques used overseas haven't been cleared for the U.S. market... There are a number of promising contraceptive developments on the horizon, some of which already are in use outside the U.S. These include a contraceptive vaccine, reversible male and female sterilization procedures, long-lasting contraceptives that can be implanted under a woman's skin, new spermicides that help reduce the risk of venereal disease, and new male contraceptives that interfere with the production of sperm. But without new spending on research and a different regulatory climate, Americans will continue to depend on 20-year-old birth control technology, said Luigi Mastroianni Jr., the committee's chairman.

1978 ◽  
Vol 46 (2) ◽  
pp. 501-502 ◽  
Author(s):  
Dale O. Jorgenson

A measure of the strength of future orientation in a sample of 350 college students correlated positively with the perceived seriousness of the U.S. and world population problems as well as the likelihood of using a variety of birth control techniques. Correlations were low (.20 to .30).


Author(s):  
Judith Giesberg

In February 1865, Congress passed the first ever federal antipornography law as a war measure intended to preserve the morality and secure the fighting strength of men serving in the U.S. Army. But the measure also marked the beginning of a postwar surge of legislation protecting morality and marriage and resurrecting a gender order that congressmen believed the war had upset. The Young Men’s Christian Association (YMCA) and Anthony Comstock lobbied successfully for a follow up measure that became known as the Comstock Law (1873). This law extended the wartime concern for endangered manhood into a series of measures aimed at pornography and restricting women’s access to birth control and abortion. These latter laws remained in place for decades. The instinct to regulate American morality by controlling women’s sexual expression became one of the U.S. Civil War’s longest cultural legacies.


1999 ◽  
Vol 82 (08) ◽  
pp. 494-499 ◽  
Author(s):  
Mary Chamberland

IntroductionSince blood is a biological product, it is a natural vehicle for transmission of infectious agents, and until an artificial blood substitute is developed, the risk of transfusion-transmitted infections will probably not be eliminated. Three agencies of the Department of Health and Human Services–the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Institutes of Health (NIH)–have collaborated with partners in local and state public health departments, academia, industry, and consumers to develop prevention strategies addressing emerging infectious disease threats to public health, including the safety of the U.S. blood supply. Four critical components of these prevention strategies are as follows: surveillance and response capabilities; integration of laboratory science and epidemiology (i.e., “applied research”) to optimize public health practice; prevention and control activities to enhance communication of public health information; and a strengthening of local, state, and federal infrastructures to support these activities.1 As highlighted by the Institute of Medicine, in its series of reports about the ongoing threat to health posed by emerging infectious diseases, surveillance is the critical lynchpin for the public health response to both known and unrecognized pathogenic threats.2 Surveillance data can be used to monitor and track temporal and demographic trends of disease, alert us to outbreaks or unexpected alterations in disease frequency or affected populations, serve as a basis for subsequent epidemiologic and laboratory investigations to describe the natural history of a disease or identify risk factors for its occurrence, and evaluate intervention strategies.2,3 This paper will review programs of surveillance in the U.S. to detect established and emerging infectious risks, with an emphasis on those that address blood safety. In addition, recent examples or case studies that illustrate the responsiveness of U.S. surveillance systems to blood safety issues will be presented.


1984 ◽  
Vol 98 ◽  
pp. 220-240 ◽  
Author(s):  
Wong Siu-lun

After several ebbs and flows a new high-tide in population control has been gathering force since 1978. This new birth control campaign has three major features which separate it from earlier ones: consensus as to its desirability among the top leadership, the high priority being awarded to it, and a sense of urgency in achieving results.


1981 ◽  
Vol 6 (1) ◽  
pp. 89-106 ◽  
Author(s):  
Joseph McFalls ◽  
George Masnick

Sign in / Sign up

Export Citation Format

Share Document